---
title: "Cement and Energy Stocks Drive Hong Kong Small-Cap Divergence Through Overseas Expansion"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/303363387.md"
description: "West Cement (2233.HK) derives 48.09% of revenue from overseas, while SPT Energy turned profitable after Indonesian drilling success. United Laboratories (3933.HK) secured regulatory filing for diabetes drug, and China In-Tech shifted 46.69% of revenue to IT services, highlighting strategic pivots among Hong Kong small-caps."
datetime: "2026-10-28T09:20:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/303363387.md)
  - [en](https://longbridge.com/en/news/303363387.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/303363387.md)
generator: "portal-rs"
---

# Cement and Energy Stocks Drive Hong Kong Small-Cap Divergence Through Overseas Expansion

Hong Kong small-cap stocks are diverging sharply as some firms tap overseas markets and strategic pivots. West Cement (2233.HK) now sources 48.09% of revenue from abroad, with stable pricing in Uganda and Ethiopia driving a 'buy' rating from Guotai Haiguan. SPT Energy (1251.HK) turned profitable after its Indonesian drilling operation identified oil and gas zones, lifting overseas revenue by 16.1% year-on-year. Link Holdings (8237.HK) nearly doubled net profit as its Kaga Hanatsubaki Hotel in Japan tests sleep-health themed rooms.

China In-Tech (0464.HK) shifted 46.69% of revenue to IT services amid a 49.9% drop in haircare appliance sales. United Laboratories (3933.HK) secured China's NMPA acceptance for its diabetes drug application, signaling core business recovery. FSE Lifestyle (0331.HK) won HKD 2.3 billion in Northern Metropolis contracts despite declining engineering revenue, while Safety Warehouse (0237.HK) acquired HKD 64.93 million in Hong Kong Island properties to boost its property investment segment to 65.34% of total revenue.

Domestic-focused firms face headwinds: Smart City Dev (8268.HK) saw construction revenue grow just 0.18%, with shares down ~6% recently. ELL ENV (1395.HK) reported a 28.72% revenue drop in waste management. Jilin Changlong Pharma (8049.HK) maintained 83.9% gross margin despite a slight sales dip. Analysts note overseas exposure and high-value service transitions are creating pockets of resilience in this segment.

### Related Stocks

- [08268.HK](https://longbridge.com/en/quote/08268.HK.md)
- [00237.HK](https://longbridge.com/en/quote/00237.HK.md)
- [00464.HK](https://longbridge.com/en/quote/00464.HK.md)
- [02233.HK](https://longbridge.com/en/quote/02233.HK.md)
- [01251.HK](https://longbridge.com/en/quote/01251.HK.md)
- [01395.HK](https://longbridge.com/en/quote/01395.HK.md)
- [00331.HK](https://longbridge.com/en/quote/00331.HK.md)
- [03933.HK](https://longbridge.com/en/quote/03933.HK.md)
- [08049.HK](https://longbridge.com/en/quote/08049.HK.md)
- [08237.HK](https://longbridge.com/en/quote/08237.HK.md)

## Related News & Research

- [United Laboratories Wins China Approval for UBT48128 Obesity Drug Trial](https://longbridge.com/en/news/306129950.md)
- [Huinan Changlong Says Planned Allocations Cover About 90% of Cash and Short-Term Investments](https://longbridge.com/en/news/304990864.md)
- [China Accepts United Laboratories’ Semaglutide Weight-Management Application](https://longbridge.com/en/news/304289761.md)
- [FSE Lifestyle Services Publishes ESG Report](https://longbridge.com/en/news/303363369.md)
- [MBV International Buys 9.96% Stake in Link Holdings for HK$ 20.03 Million](https://longbridge.com/en/news/303746555.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**